Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve Intimation of the date of Board Meeting

pdf

Biocon Ltd.

01 Oct 2025

364.30

2.29%

Board Meeting

Biocon Ltd - 532523 - Board Meeting Outcome for Early Redemption Of Ncds

BSE India

The Board of Directors of the Company at its meeting held today has approved the early full redemption of 1,07,000 unlisted, secured, rated, redeemable, Non-Convertible Debentures (NCDs) of face value of INR 1,00,000/- each, aggregating to Rs. 1,070 Crores, issued and allotted by the Company on private placement basis on February 21, 2023. Further, please be informed that the Company has made payment of due consideration today as per agreement with concerned debenture holders and the debenture trustee towards the aforesaid early full redemption of the NCDs.

pdf

Biocon Ltd.

01 Oct 2025

364.30

2.29%

Company Update

Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release

pdf

Biocon Ltd.

28 Sep 2025

364.30

2.29%

Board Meeting

Biocon Ltd - 532523 - Board Meeting Intimation for Proposed Early Redemption Of Unlisted, Secured, Rated, …

BSE India

Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/10/2025 ,inter alia, to consider and approve It is proposed to consider early redemption of unlisted, secured, rated, redeemable, Non-Convertible Debentures (NCDs) of face value of INR 1,00,000/- each, issued and allotted by the Company on private placement basis on February 21, 2023, subject to approval of the Board of Directors of the Company proposed to be sought on October 01, 2025, and receipt of necessary approvals, on such date as may be determined by the Company.

pdf

Is Biocon Ltd. worth buying?

728 Votes:

Buy 75.0%

Sell 16.35%

Hold 8.65%

RESEARCH REPORTS

Sell SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf